Buy & Sell Devon Energy Corp (DVN) – Devon Energy Corp Price Today
Aura AI Summary
Key Stats
- $52.26BMarket Cap
- EnergySector
- -15.36%3M Drawdown
- $59.04BEnterprise Value
- 2.3%Dividend Yield
- 129 daysTypical Hold Time
Devon Energy Corp (DVN) is currently valued at a market capitalization of $52.26B, with an enterprise value of $59.04B. Over the past 52 weeks, Devon Energy Corp has traded between a low of $31.74 and a high of $52.07, highlighting its annual price range. Over the past three months, Devon Energy Corp has recorded a drawdown of -15.36%, reflecting recent price volatility. Devon Energy Corp offers a dividend yield of 2.3%, with the most recent dividend of $0.24 paid on 13 Mar 26. On average, investors hold Devon Energy Corp for approximately 129 days, indicating typical investor behavior on the platform.
About Devon Energy Corp
Devon Energy, based in Oklahoma City, is one of the largest independent exploration and production companies in North America. The firm's asset base is spread throughout onshore North America and includes exposure to the Delaware, STACK, Eagle Ford, Powder River Basin, and Bakken plays. At year-end 2021, Devon's proved reserves totaled 1.6 billion barrels of oil equivalent, and net production that year was 572 thousand boe/d, of which oil and natural gas liquids made up 74% of production, with natural gas accounting for the remainder.
Most Recent News
Harvest Investment Services sells 356,000 shares of Adaptive Biotechnologies worth $5.7M
Harvest Investment Services has sold 356,000 shares of Adaptive Biotechnologies, totaling approximately $5.7 million. This significant sale may impact the stock's market perception and price. Investors should watch for any further moves by major shar...
Ascentage Pharma reveals promising clinical data for olverembatinib and lisaftoclax in blood cancer treatments at EHA2026.
Ascentage Pharma presented 17 clinical updates on its key cancer drugs olverembatinib and lisaftoclax at the EHA2026 Congress, showing strong efficacy and safety in treating various blood cancers including chronic myeloid leukemia (CML) and Philadelp...
Fed Chair Kevin Warsh's first meeting sparks uncertainty over future rate policies.
Kevin Warsh held his first Federal Reserve meeting as chairman, drawing attention due to his mixed signals on interest rate policy. Known for advocating rate hikes, Warsh recently promised major changes including potential rate cuts favored by the Wh...